Cervical Adenocarcinoma Cell HeLa-S3 Transfection Kit

Modes of administration

Reagent exhibits at least 94% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.

Description

The HeLa S3 cell line is an immortal cell line that shares many similarities with the famous HeLa cell line. It is a derivative of the HeLa cell line and was established in 1955 as the third clone from the original culture. The "S" in its name honors Dr. Florence Rena Sabin, even though it was established in the lab of Dr. Theodore Puck. HeLa S3 has been extensively used in mammalian cloning research and has similar properties to the original HeLa cell line, named after Henrietta Lacks, from which it was derived.

Although HeLa S3 cells share many similarities with the original HeLa cells, there are some critical differences. HeLa S3 cells have a different karyotype than the original HeLa cells and tend to be more homogeneous in their growth and morphology. As a result, they are easier to work with in certain types of experiments. They have been used in a wide variety of research areas, including cancer biology, virology, and drug discovery. The HeLa S3 transfection reagent kit for cervical adenocarcinoma, among other transfection products, is offered by CD BioSciences and yields high transfection efficiency of siRNA delivery. It also produces high-level recombinant protein expression with minimal disruption of cell function and low cytotoxicity.